CN105136928A - Method for fast detecting whole red blood cell octadecadienoic acid - Google Patents
Method for fast detecting whole red blood cell octadecadienoic acid Download PDFInfo
- Publication number
- CN105136928A CN105136928A CN201510545120.4A CN201510545120A CN105136928A CN 105136928 A CN105136928 A CN 105136928A CN 201510545120 A CN201510545120 A CN 201510545120A CN 105136928 A CN105136928 A CN 105136928A
- Authority
- CN
- China
- Prior art keywords
- red blood
- whole blood
- blood cell
- detection
- dienoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003743 erythrocyte Anatomy 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 37
- ADHNUPOJJCKWRT-JLXBFWJWSA-N (2e,4e)-octadeca-2,4-dienoic acid Chemical compound CCCCCCCCCCCCC\C=C\C=C\C(O)=O ADHNUPOJJCKWRT-JLXBFWJWSA-N 0.000 title description 7
- 238000001514 detection method Methods 0.000 claims abstract description 55
- 210000004369 blood Anatomy 0.000 claims abstract description 12
- 239000008280 blood Substances 0.000 claims abstract description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- ADHNUPOJJCKWRT-UHFFFAOYSA-N octadeca-2,4-dienoic acid Chemical compound CCCCCCCCCCCCCC=CC=CC(O)=O ADHNUPOJJCKWRT-UHFFFAOYSA-N 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 claims description 8
- 238000004949 mass spectrometry Methods 0.000 claims description 7
- 239000012159 carrier gas Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 239000007789 gas Substances 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 3
- 229910052734 helium Inorganic materials 0.000 claims description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 3
- 238000010926 purge Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 2
- 238000010792 warming Methods 0.000 claims 2
- 230000004907 flux Effects 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000002203 pretreatment Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 239000002253 acid Substances 0.000 abstract description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 26
- 229930195729 fatty acid Natural products 0.000 description 26
- 239000000194 fatty acid Substances 0.000 description 26
- 150000004665 fatty acids Chemical class 0.000 description 26
- 150000002500 ions Chemical class 0.000 description 22
- 239000000243 solution Substances 0.000 description 9
- 238000004817 gas chromatography Methods 0.000 description 8
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 5
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 235000004626 essential fatty acids Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 4
- 150000004702 methyl esters Chemical class 0.000 description 4
- HUEBIMLTDXKIPR-UHFFFAOYSA-N methyl heptadecanoate Chemical compound CCCCCCCCCCCCCCCCC(=O)OC HUEBIMLTDXKIPR-UHFFFAOYSA-N 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- NYSGGOVWVWBZAA-UHFFFAOYSA-N Octadecadienoic acid, methyl ester Chemical compound CCCCCCCCCCCCCC=CC=CC(=O)OC NYSGGOVWVWBZAA-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 235000019581 fat taste sensations Nutrition 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- ISYWECDDZWTKFF-UHFFFAOYSA-N nonadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(O)=O ISYWECDDZWTKFF-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 208000013521 Visual disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WTTJVINHCBCLGX-NQLNTKRDSA-N methyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC WTTJVINHCBCLGX-NQLNTKRDSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000581 reactive spray deposition Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 235000020807 short-term diet Nutrition 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明提供一种快速检测全血红细胞十八烷二烯酸的方法,属于生物检测技术领域,包括如下步骤:A)全血样品的前处理;B)对所述样品检测液采用气相色谱-质谱仪进行检测。本发明提供的检测方法具有样品用量少,前处理简单,灵敏度高,特异性强,定性、定量功能强大,并且整个检测过程时间短、检测通量高等优点。
The invention provides a method for rapidly detecting octadecadenoic acid in whole blood erythrocytes, belonging to the technical field of biological detection, comprising the following steps: A) pretreatment of whole blood samples; B) using gas chromatography- mass spectrometer for detection. The detection method provided by the invention has the advantages of less sample consumption, simple pretreatment, high sensitivity, strong specificity, powerful qualitative and quantitative functions, short time in the whole detection process, and high detection throughput.
Description
技术领域 technical field
本发明属于生物检测技术领域,涉及一种快速检测全血红细胞十八烷二烯酸的方法。 The invention belongs to the technical field of biological detection, and relates to a method for rapidly detecting octadecanedienoic acid in whole blood red blood cells.
背景技术 Background technique
在人体内,少量脂肪酸以游离形式存在,大部分以结合形式,如甘油三酯、磷脂、糖脂等存在。从营养学角度,脂肪酸可分为必需脂肪酸和非必需脂肪酸,非必需脂肪酸是指机体可以自行合成,不必依靠食物供应的脂肪酸;必需脂肪酸是指人体维持机体正常代谢不可缺少而自身又不能合成或合成速度慢,无法满足机体需要,必须通过食物供给的脂肪酸。必需脂肪酸可分为ω(Omega)-6系列脂肪酸和ω(Omega)-3系列脂肪酸。膳食中必需脂肪酸缺乏将导致皮肤病变、神经和视觉疑难症、心脏疾病等问题。 In the human body, a small amount of fatty acids exist in free form, and most of them exist in bound form, such as triglycerides, phospholipids, glycolipids, etc. From a nutritional point of view, fatty acids can be divided into essential fatty acids and non-essential fatty acids. Non-essential fatty acids refer to fatty acids that can be synthesized by the body without relying on food supply; The synthesis rate is slow, unable to meet the needs of the body, and must be supplied by food. Essential fatty acids can be divided into omega (Omega)-6 series fatty acids and omega (Omega)-3 series fatty acids. Dietary deficiencies in essential fatty acids can lead to skin lesions, neurological and visual disorders, heart disease and other problems.
由于红细胞膜上脂肪酸的组成能够反映人群的长期饮食结构,而不会受到短期内饮食的影响。因此,测定人全血红细胞脂肪酸,能够准确、客观的反映机体内不同脂肪酸的营养水平。 Since the composition of fatty acids on red blood cell membranes can reflect the long-term dietary structure of the population, it will not be affected by short-term diet. Therefore, the determination of human whole blood erythrocyte fatty acids can accurately and objectively reflect the nutritional levels of different fatty acids in the body.
国内外有关脂肪酸检测的相关报道盛多,涉及到食品、环境、医药卫生、临床应用等多个领域,检测方法包括气相色谱法(GC)、气相色谱-质谱法(GC-MS)和液相色谱-串联质谱法(LC-MS/MS),检测样本类型更是涉及食物、水质、药品、血液、组织等。但是,不同的应用领域及不同的样品类型,所涉及的样品处理与脂肪酸检测分析流程千差万别,因此不同领域以及不同样品类型的脂肪酸检测方法之间无可比性。 There are many reports on the detection of fatty acids at home and abroad, involving food, environment, medicine and health, clinical applications and other fields. The detection methods include gas chromatography (GC), gas chromatography-mass spectrometry (GC-MS) and liquid chromatography. Chromatography-tandem mass spectrometry (LC-MS/MS), the type of detection sample is related to food, water quality, medicine, blood, tissue, etc. However, different application fields and different sample types involve different sample processing and fatty acid detection and analysis procedures, so there is no comparison between fatty acid detection methods in different fields and different sample types.
目前,全血红细胞脂肪酸的检测主要有GC、GC-MS和LC-MS/MS三种。GC是目前红细胞脂肪酸检测的常用方法,但是此方法的检测器对未实现色谱分离的类似脂肪酸,无法实现准确定性分离和定量分析,因此无法对多种脂肪酸特异性、准确的定性和定量分析。LC-MS/MS方法前处理较为复杂,且分析结果重现性较差。而GC-MS方法由于同时具有气相的分离功能和质谱的特异性定性、定量功能,所以可以解决GC和LC-MS/MS的弊端,但是现有的GC-MS方法分析时间较长,检测通量较低。 At present, there are three main methods for the detection of fatty acids in whole blood red blood cells: GC, GC-MS and LC-MS/MS. GC is currently a common method for the detection of red blood cell fatty acids, but the detector of this method cannot achieve accurate qualitative separation and quantitative analysis of similar fatty acids that have not been chromatographically separated, so it cannot perform specific and accurate qualitative and quantitative analysis of various fatty acids. The pretreatment of LC-MS/MS method is relatively complicated, and the reproducibility of analysis results is poor. The GC-MS method can solve the disadvantages of GC and LC-MS/MS because it has the separation function of the gas phase and the specific qualitative and quantitative functions of the mass spectrometer. The amount is lower.
中国专利201210247480.2公开了一种气相色谱-质谱联用检测脂肪酸含量的方法,该方法针对的样品为动物组织,样品的前处理包括皂化步骤,还需要充氮气保护,样品的前处理复杂。 Chinese patent 201210247480.2 discloses a method for detecting fatty acid content by gas chromatography-mass spectrometry. The sample used in this method is animal tissue. The pretreatment of the sample includes a saponification step, and nitrogen protection is also required. The pretreatment of the sample is complicated.
因此,本领域技术人员迫切需要一种前处理简单、检测快速、方法灵敏度高、特异性强的适用于全血红细胞脂肪酸的检测方法。 Therefore, those skilled in the art urgently need a method for detecting fatty acids in whole blood red blood cells that is simple in pretreatment, fast in detection, high in sensitivity and strong in specificity.
发明内容 Contents of the invention
为了解决现有技术中存在的问题,本发明提供一种快速检测全血红细胞十八烷二烯酸的方法,该方法的样品用量少,前处理简单,灵敏度高,特异性强,定性、定量功能强大,并且整个检测过程时间短、检测通量高。本发明仅涉及全血样本红细胞十八烷二烯酸的检测。 In order to solve the problems existing in the prior art, the present invention provides a method for rapidly detecting octadecadenoic acid in whole blood erythrocytes. The method requires less sample consumption, simple pretreatment, high sensitivity, strong specificity, qualitative, The quantitative function is powerful, and the whole detection process is short and the detection throughput is high. The present invention only relates to the detection of erythrocyte octadecadienoic acid in whole blood samples.
一种快速检测全血红细胞十八烷二烯酸的方法,包括如下步骤: A method for rapidly detecting octadecadienoic acid in whole blood erythrocytes, comprising the steps of:
A)全血样品的前处理:从全血样品中分离红细胞,加入内标溶液和盐酸-甲醇溶液进行衍生化反应,然后加入萃取剂萃取,取上清液并氮气吹干,残渣中加入复溶剂,混匀,得到样品检测液; A) Pretreatment of whole blood samples: separate erythrocytes from whole blood samples, add internal standard solution and hydrochloric acid-methanol solution for derivatization reaction, then add extractant for extraction, take supernatant and blow dry with nitrogen, add complex to the residue Solvent, mixed, to obtain the sample detection solution;
B)对所述样品检测液采用气相色谱-质谱仪进行检测,气相色谱条件包括:色谱柱采用极性色谱柱,载气为氦气,不分流进样,线速度流量控制方式,载气流量为0.80~1.00mL/min,起始柱温60℃,先升温至180℃,然后升温至220℃,整个升温程序的梯度时间为8~15min;质谱条件为:采用电子轰击离子源,采用全扫描和选择离子扫描方式。 B) The sample detection solution is detected by gas chromatography-mass spectrometer. The gas chromatography conditions include: the chromatographic column adopts a polar chromatographic column, the carrier gas is helium, splitless injection, linear velocity flow control mode, carrier gas flow rate The temperature is 0.80~1.00mL/min, the initial column temperature is 60°C, the temperature is first raised to 180°C, and then the temperature is raised to 220°C, the gradient time of the whole temperature rise program is 8~15min; the mass spectrometry conditions are: electron bombardment ion source, Scanning and Selected Ion Scanning Mode.
采用上述技术方案,前处理简单,通过萃取-吹干-复溶的过程,有效去除了干扰物质,使红细胞中的十八烷二烯酸转化为挥发性较强、适用于气相色谱质谱仪检测的十八烷二烯酸甲酯产物;检测方法的灵敏度高,特异性强,定性、定量功能强大,准确性好,并且整个检测过程时间短、检测通量高。 Adopting the above-mentioned technical scheme, the pretreatment is simple, and through the process of extraction-drying-reconstitution, the interfering substances are effectively removed, and the octadecadienoic acid in red blood cells is converted into a highly volatile product suitable for detection by gas chromatography-mass spectrometers. Octadecanadienoic acid methyl ester product; the detection method has high sensitivity, strong specificity, strong qualitative and quantitative functions, good accuracy, and the whole detection process is short in time and high in detection throughput.
优选地,所述内标溶液选自十七烷酸。除十七烷酸,外本发明还可以选用十五烷酸或十九烷酸作为内标溶液。 Preferably, the internal standard solution is selected from heptadecanoic acid. In addition to heptadecanoic acid, pentadecanoic acid or nonadecanoic acid can also be used as the internal standard solution in the present invention.
优选地,所述萃取剂选自正己烷,所述复溶剂选自正己烷。使用正己烷作为萃取剂,可以将各种脂肪酸的甲酯化产物萃取出来,萃取效率高且有效避免了其他物质的干扰。 Preferably, the extractant is selected from n-hexane, and the reconstituted solvent is selected from n-hexane. Using n-hexane as the extractant, the methyl esterification products of various fatty acids can be extracted, the extraction efficiency is high and the interference of other substances is effectively avoided.
优选地,所述内标溶液与红细胞的体积比为1:(1~2);所述红细胞、盐酸-甲醇溶液、萃取剂及复溶剂的体积比为1:(10~25):(20~50):(4~10)。 Preferably, the volume ratio of the internal standard solution to red blood cells is 1:(1~2); the volume ratio of the red blood cells, hydrochloric acid-methanol solution, extractant and reconstitution solvent is 1:(10~25):(20 ~50): (4~10).
优选地,所述红细胞、盐酸-甲醇溶液、萃取剂及复溶剂的体积比为1:20:40:8。 Preferably, the volume ratio of the red blood cells, hydrochloric acid-methanol solution, extraction agent and reconstitution agent is 1:20:40:8.
优选地,所述极性色谱柱选自规格为20m*0.18mm*0.20μm的极性毛细管色谱柱。 Preferably, the polar chromatographic column is selected from polar capillary chromatographic columns with specifications of 20m*0.18mm*0.20μm.
优选地,所述气相色谱条件还包括:进样体积为1μL,进样口温度为220~230℃,后运行温度为240~250℃,后运行时间为2min,吹扫流量为3.0~5.0mL/min,总流量为50.0~60.0mL/min,平均线速度为35.0~45.0cm/s。 Preferably, the gas chromatography conditions further include: the injection volume is 1 μL, the inlet temperature is 220-230°C, the post-run temperature is 240-250°C, the post-run time is 2min, and the purge flow rate is 3.0-5.0mL /min, the total flow rate is 50.0~60.0mL/min, and the average linear velocity is 35.0~45.0cm/s.
优选地,所述质谱条件还包括:接口温度为210~230℃;离子源温度为220~240℃;四极杆温度为140~160℃,溶剂延迟时间为3.0~4.0min,全扫描范围为m/z60.00~450.00。 Preferably, the mass spectrometry conditions also include: the interface temperature is 210~230°C; the ion source temperature is 220~240°C; the quadrupole temperature is 140~160°C, the solvent delay time is 3.0~4.0min, and the full scan range is m/z60.00~450.00.
优选地,所述检测方法还包括如下步骤:检测结果的定性判断和/或定量计算。 Preferably, the detection method further includes the following steps: qualitative judgment and/or quantitative calculation of the detection results.
与现有技术相比,本发明的有益效果是:本发明提供的检测方法可以实现全血样品红细胞中十八烷二烯酸的定性和定量检测,具有前处理简单,有效去除了干扰物质,灵敏度高,特异性强,定性、定量功能强大,准确性好,并且整个检测过程时间短、检测通量高。 Compared with the prior art, the beneficial effects of the present invention are: the detection method provided by the present invention can realize the qualitative and quantitative detection of octadecadienoic acid in the red blood cells of the whole blood sample, has the advantages of simple pretreatment, effectively removes interfering substances, High sensitivity, strong specificity, powerful qualitative and quantitative functions, good accuracy, and the whole detection process is short in time and high in detection throughput.
本发明采用全扫描和选择离子扫描同时进行的扫描模式,能够得到样品的总离子流色谱图和选择离子色谱图,总离子流色谱图可以用于对化合物进行定性,用于检测过程中监测出峰时间处的化合物是否为目标化合物,以免出现其他干扰。此外,选择离子扫描对每个化合物的特征离子进行扫描,解决了单独使用气相色谱对脂肪酸进行定量不够准确的问题,进一步提高了检测准确度和方法的特异性。本发明所使用的极性色谱柱适合十八烷二烯酸的分离分析,色谱柱的高柱效以及低流失,大大降低了质谱检测时的背景干扰,最低检出限达到了0.01mg/L,检测灵敏度高。按本发明提供的检测方法,单个样品检测时间为12min,与现有传统方法相比,检测时间短,仪器检测通量高。 The present invention adopts the scanning mode of full scan and selected ion scan at the same time, and can obtain the total ion current chromatogram and selected ion chromatogram of the sample, and the total ion current chromatogram can be used to characterize the compound and to monitor the Whether the compound at the peak time is the target compound, so as to avoid other interferences. In addition, the selected ion scan scans the characteristic ions of each compound, which solves the problem of inaccurate quantification of fatty acids using gas chromatography alone, and further improves the detection accuracy and specificity of the method. The polar chromatographic column used in the present invention is suitable for the separation and analysis of octadecanedienoic acid. The high column efficiency and low loss of the chromatographic column greatly reduce the background interference during mass spectrometry detection, and the minimum detection limit reaches 0.01mg/L. high sensitivity. According to the detection method provided by the invention, the detection time of a single sample is 12 minutes, and compared with the existing traditional method, the detection time is short and the detection throughput of the instrument is high.
附图说明 Description of drawings
图1十八烷二烯酸甲酯的标准曲线。 Figure 1 Standard curve of octadecadedienoic acid methyl ester.
图2全血红细胞样品中脂肪酸甲酯的总离子流色谱图。 Figure 2 Total ion chromatogram of fatty acid methyl esters in whole blood red blood cell samples.
图3全血红细胞样品中十八烷二烯酸甲酯的选择离子色谱图。 Figure 3 Selected ion chromatograms of methyl octadecadienoate in red blood cell samples from whole blood.
图4全血红细胞样品中十七烷酸甲酯的选择离子色谱图。 Figure 4 Selected ion chromatogram of methyl heptadecanoate in whole blood red blood cell samples.
具体实施方式 Detailed ways
下面结合附图和实施例对本发明做进一步详细说明。 The present invention will be described in further detail below in conjunction with the accompanying drawings and embodiments.
实施例一全血样品的前处理The pretreatment of embodiment one whole blood sample
将抗凝全血样本混匀,离心,弃除上层血浆、白细胞、血小板等;向剩余红细胞中加入等体积的生理盐水,混匀后离心,弃除上层的生理盐水;再向剩余的红细胞中加入等体积的生理盐水,混匀后即得到分离好的红细胞样品。 Mix the anticoagulated whole blood sample, centrifuge, discard the upper layer of plasma, white blood cells, platelets, etc.; add an equal volume of normal saline to the remaining red blood cells, mix and centrifuge, discard the upper layer of normal saline; then add the remaining red blood cells Add an equal volume of normal saline and mix well to obtain the separated red blood cell sample.
取50μL红细胞样品,置于螺旋盖玻璃离心管中,加入十七烷酸作为内标溶液,加入1mL3mol/L的盐酸-甲醇溶液,混匀后置烘箱中,90℃避光反应3h,衍生化反应完毕后,冷却至室温,加入2mL正己烷萃取甲酯化反应产物,取上清液并进行氮气吹干,然后向残渣中加入正己烷作为复溶剂,混匀,得到样品检测液。其中,十七烷酸与红细胞样品的体积比为1:1;红细胞样品、盐酸-甲醇溶液、萃取剂及复溶剂的体积比为1:20:40:8。 Take 50 μL red blood cell sample, put it in a glass centrifuge tube with screw cap, add heptadecanoic acid as an internal standard solution, add 1 mL of 3mol/L hydrochloric acid-methanol solution, mix well, put it in an oven, react at 90°C for 3 hours in the dark, and derivatize After the reaction was completed, cool to room temperature, add 2 mL of n-hexane to extract the methyl esterification reaction product, take the supernatant and dry it with nitrogen, then add n-hexane to the residue as a reconstitution solvent, mix well, and obtain a sample detection solution. Among them, the volume ratio of heptadecanoic acid to red blood cell sample is 1:1; the volume ratio of red blood cell sample, hydrochloric acid-methanol solution, extraction agent and reconstitution solvent is 1:20:40:8.
通过上述前处理,将红细胞中的脂肪酸转化为挥发性较强、适用于气相色谱-质谱仪检测的脂肪酸甲酯产物,并萃取分离出来,有效避免了其他物质对后续检测的干扰。 Through the above pretreatment, fatty acids in red blood cells are converted into highly volatile fatty acid methyl ester products suitable for detection by gas chromatography-mass spectrometry, and extracted and separated, effectively avoiding the interference of other substances on subsequent detection.
实施例二全血红细胞脂肪酸的检测Example 2 Detection of whole blood erythrocyte fatty acids
将样品检测液使用气相色谱-质谱仪进行检测。 The sample detection solution is detected by gas chromatography-mass spectrometer.
色谱条件包括:色谱柱为规格为20m*0.18mm(ID)*0.20μm(film)的极性毛细管色谱柱(购自安捷伦,型号DB-23,PartNumber122-2361),载气为99.999%纯度的氦气,载气流速为0.90mL/min,进样方式为不分流进样,进样体积为1μL,进样口温度为230℃,后运行温度为240℃,后运行时间为2min,吹扫流量为4.0mL/min,总流量为55mL/min。程序升温条件如表1所示。 The chromatographic conditions include: the chromatographic column is a polar capillary column with a specification of 20m*0.18mm (ID)*0.20μm (film) (purchased from Agilent, model DB-23, PartNumber122-2361), and the carrier gas is 99.999% pure Helium, the carrier gas flow rate is 0.90mL/min, the sampling method is splitless injection, the injection volume is 1 μL, the inlet temperature is 230°C, the post-run temperature is 240°C, the post-run time is 2min, and the purge The flow rate is 4.0mL/min, and the total flow rate is 55mL/min. The temperature programming conditions are shown in Table 1.
质谱检测采用电子轰击电离模式,采用全扫描和选择离子扫描方式。质谱条件包括:电离源为电子轰击离子源(EI),70ev;传输线温度为230℃,离子源温度为250℃,四极杆质量分析器温度为150℃,溶剂延迟时间为3.70min;扫描模式为全扫描(Scan)和选择离子扫描(SIM),全扫描范围为m/z60.00~450.00,选择离子扫描(SIM)模式参数如表2所示。 Mass spectrometry detection adopts electron bombardment ionization mode, and adopts full scan and selected ion scan methods. Mass spectrometry conditions include: ionization source is electron bombardment ion source (EI), 70ev; transfer line temperature is 230°C, ion source temperature is 250°C, quadrupole mass analyzer temperature is 150°C, solvent delay time is 3.70min; scan mode It is a full scan (Scan) and a selected ion scan (SIM), the full scan range is m/z60.00~450.00, and the parameters of the selected ion scan (SIM) mode are shown in Table 2.
全血红细胞中脂肪酸的定性、定量检测:以样品中各脂肪酸与标准品的甲酯产物保留时间、全扫描所得的质谱图进行NIST谱库检索以及与标准物质的质谱图进行比对作为定性依据,各脂肪酸甲酯的保留时间如表3所示。样品色谱图中所选择的定性定量离子的相对丰度比与标准溶液的离子相对丰度比的偏差不超过预设规定范围,则可以判断样品中存在对应的目标物质。用内标标准曲线法定量,十八烷二烯酸甲酯的峰面积与相应内标物甲酯峰面积的比值为纵坐标,十八烷二烯酸的浓度与内标物的浓度比值为横坐标,绘制标准曲线,结果如图1所示,计算人红细胞十八烷二烯酸的含量。 Qualitative and quantitative detection of fatty acids in whole blood red blood cells: the retention time of each fatty acid in the sample and the methyl ester product of the standard, the mass spectrum obtained from the full scan, the NIST spectral library search and the comparison with the mass spectrum of the standard substance as the qualitative basis , the retention times of each fatty acid methyl ester are shown in Table 3. If the deviation between the relative abundance ratio of the qualitative and quantitative ions selected in the sample chromatogram and the ion relative abundance ratio of the standard solution does not exceed the preset specified range, it can be determined that there is a corresponding target substance in the sample. Quantitative with internal standard standard curve method, the ratio of the peak area of octadecadienoic acid methyl ester and corresponding internal standard methyl ester peak area is ordinate, the concentration ratio of octadecadienoic acid and internal standard is The abscissa draws a standard curve, the results are shown in Figure 1, and the content of octadecadienoic acid in human erythrocytes is calculated.
采用上述方法,对1例全血红细胞样品中的脂肪酸进行了检测,得出了20种脂肪酸各自的含量,脂肪酸甲酯的总离子流色谱图如图2所示。从图2可以看出,各脂肪酸甲酯峰型对称,没有拖尾现象,分离效果很好。全血红细胞样品中,十八烷二烯酸甲酯的选择离子色谱图如图3所示,十七烷酸甲酯的选择离子色谱图如图4所示。 Using the above method, the fatty acids in a sample of whole blood red blood cells were detected, and the respective contents of 20 fatty acids were obtained. The total ion chromatogram of fatty acid methyl esters is shown in Fig. 2 . It can be seen from Figure 2 that the peak shapes of fatty acid methyl esters are symmetrical, there is no tailing phenomenon, and the separation effect is very good. In the whole blood red blood cell sample, the selected ion chromatogram of octadecadienoic acid methyl ester is shown in Figure 3, and the selected ion chromatogram of heptadecanoic acid methyl ester is shown in Figure 4.
本发明的检测方法最低检出限达到了0.01mg/L,得出人红细胞样品中20种脂肪酸在测定的浓度范围内,线性良好,决定系数R2在0.996-0.999之间。 The minimum detection limit of the detection method of the present invention reaches 0.01 mg/L, and it is obtained that the 20 kinds of fatty acids in the human red blood cell sample are within the determined concentration range, and the linearity is good, and the coefficient of determination R2 is between 0.996-0.999 .
重复性实验:取同一来源的全血样品5份,进行相同的前处理和检测,结果20种脂肪酸含量的RSD都在3%~8%之间,表明该方法的重复性好。 Reproducibility experiment: 5 whole blood samples from the same source were taken and subjected to the same pretreatment and detection. As a result, the RSDs of the contents of 20 fatty acids were all between 3% and 8%, indicating that the method had good repeatability.
以上内容是结合具体的优选实施方式对本发明所作的进一步详细说明,不能认定本发明的具体实施只局限于这些说明。对于本发明所属技术领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干简单推演或替换,都应当视为属于本发明的保护范围。 The above content is a further detailed description of the present invention in conjunction with specific preferred embodiments, and it cannot be assumed that the specific implementation of the present invention is limited to these descriptions. For those of ordinary skill in the technical field of the present invention, without departing from the concept of the present invention, some simple deduction or replacement can be made, which should be regarded as belonging to the protection scope of the present invention.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510545120.4A CN105136928A (en) | 2015-08-31 | 2015-08-31 | Method for fast detecting whole red blood cell octadecadienoic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510545120.4A CN105136928A (en) | 2015-08-31 | 2015-08-31 | Method for fast detecting whole red blood cell octadecadienoic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105136928A true CN105136928A (en) | 2015-12-09 |
Family
ID=54722353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510545120.4A Pending CN105136928A (en) | 2015-08-31 | 2015-08-31 | Method for fast detecting whole red blood cell octadecadienoic acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105136928A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6428990B1 (en) * | 1997-04-11 | 2002-08-06 | Abbott Laboratories | Human desaturase gene and uses thereof |
| CN1920554A (en) * | 2005-08-23 | 2007-02-28 | 天津贝特药业有限公司 | Method for measuring OMEGA3 unsaturated fatty acid ester in seal oil |
-
2015
- 2015-08-31 CN CN201510545120.4A patent/CN105136928A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6428990B1 (en) * | 1997-04-11 | 2002-08-06 | Abbott Laboratories | Human desaturase gene and uses thereof |
| CN1920554A (en) * | 2005-08-23 | 2007-02-28 | 天津贝特药业有限公司 | Method for measuring OMEGA3 unsaturated fatty acid ester in seal oil |
Non-Patent Citations (6)
| Title |
|---|
| D.R EVANS 等: "Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment", 《PROSTAGLANDINS, LEUKOTRIENES AND ESSENTIAL FATTY ACIDS》 * |
| DE-CAI WANG 等: "Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer’s disease", 《NEUROBIOLOGY OF AGING》 * |
| E.O. ABU 等: "Omega-3 index determined by gas chromatography with electron impact mass spectrometry", 《PROSTAGLANDINS, LEUKOTRIENES AND ESSENTIAL FATTY ACIDS》 * |
| NAIN,S.等: "Characterization of the n-3 polyunsaturated fatty acid enrichment in laying hens fed an extruded flax enrichment source", 《POULT.SCI.》 * |
| S. NAIN 等: "Camelina sativa cake for broilers: Effects of increasing dietary inclusion from 0 to 24% on tissue fatty acid proportions at 14, 28, and 42 d of age", 《POULTRY SCIENCE》 * |
| 张秀娟 等: "紫草多糖对S180小鼠红细胞膜磷脂脂肪酸的影响", 《哈尔滨商业大学学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Villas‐Bôas et al. | Mass spectrometry in metabolome analysis | |
| Li et al. | Comparative analysis of nucleosides and nucleobases from different sections of Elaphuri Davidiani Cornu and Cervi Cornu by UHPLC–MS/MS | |
| CN103884782B (en) | Based on the extensive blood plasma sphingolipid method for profile analysis of liquid chromatograph mass spectrography | |
| Aarika et al. | From complexity to clarity: expanding metabolome coverage with innovative analytical strategies | |
| CN116124905B (en) | A method for detecting short-chain fatty acids in mouse plasma, feces or tissue samples | |
| CN105241968A (en) | Method of quickly detecting fatty acid in whole blood red cell | |
| CN105158362A (en) | Method for quickly detecting octadecanoic acid of whole blood erythrocytes | |
| Yao et al. | HILIC‐UPLC‐MS/MS combined with hierarchical clustering analysis to rapidly analyze and evaluate nucleobases and nucleosides in Ginkgo biloba leaves | |
| CN105158363B (en) | Method for quickly detecting hexadecanoic olefine acid of whole blood erythrocytes | |
| CN105158388B (en) | A kind of method of quick detection whole blood red blood cell lignoceric acid | |
| CN105158387A (en) | Method for quickly detecting tetradecanoic acid of whole blood erythrocytes | |
| CN105158390B (en) | A kind of method of quick detection whole blood red blood cell lignocerane monoenoic acid | |
| CN105136928A (en) | Method for fast detecting whole red blood cell octadecadienoic acid | |
| CN105241970A (en) | Method of quickly detecting eicosatrienoic acid in whole blood red cell | |
| CN105241969A (en) | Method of quickly detecting docosatetraenoic acid in whole blood red cell | |
| Zhong et al. | Determination of oxylipins and their precursors in breast milk by solid phase extraction-ultra high performance liquid chromatography-triple quadrupole tandem mass spectrometry | |
| CN105181833A (en) | Method for rapid detection of whole blood erythrocyte eicosapentaenoic acid | |
| CN105158389A (en) | Method for quickly detecting all cis-7,10,13,16,19-docosapentaenoic acid of whole blood erythrocytes | |
| CN105181834A (en) | Rapid detection method of whole blood erythrocyte behenic acid | |
| CN114236016B (en) | A rapid and accurate method for the determination of 48 free fatty acids in biological samples | |
| CN105136927A (en) | Method for fast detecting whole red blood cell eicosatetraenoic acid | |
| CN105136954A (en) | Method for fast detecting whole red blood cell eicosaenoic acid | |
| CN105158361A (en) | Method for quickly detecting octadecanoic olefine acid of whole blood erythrocytes | |
| CN105181832A (en) | Method for rapid detection of whole blood erythrocyte eicosadienoic acid | |
| CN114062555B (en) | Method for measuring NMN content in dietary supplement products |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151209 |